10x Genomics, Inc. (TXG)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 02:44PM EDT. Market open.
Show:
Annual
Cash flow
All numbers in thousandsBreakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-264,301
-255,099
-166,000
-58,223
-542,731
-
Depreciation & amortisation
46,497
43,619
33,006
28,254
19,021
-
Stock-based compensation
160,978
166,950
136,848
95,962
48,626
-
Change in working capital
17,006
17,343
-39,417
-87,445
-50,381
-
Accounts receivable
-13,376
-10,613
-18,948
-34,041
-17,847
-
Inventory
-1,617
7,871
-21,192
-30,132
-14,601
-
Accounts payable
-653
-6,017
5,858
11,084
-7,770
-
Other working capital
-73,949
-64,721
-165,267
-122,651
-256,292
-
Other non-cash items
-
-
-
-
306,017
101
Net cash provided by operating activities
-26,797
-15,197
-33,606
-21,373
-217,898
-
Cash flows from investing activities
Investments in property, plant and equipment
-47,152
-49,524
-131,661
-101,278
-38,394
-
Acquisitions, net
-
0
-4,000
-5,451
0
-
Purchases of investments
-
0
-282,871
0
-
-
Sales/maturities of investments
71,320
183,016
67,645
0
-
-
Net cash used for investing activities
24,168
133,492
-350,887
-106,729
-38,394
-
Cash flows from financing activities
Debt repayment
-
-
0
0
-31,256
-11,000
Common stock issued
-
-
0
0
482,267
410,824
Common stock repurchased
-
-
-
-
-
0
Other financing activities
-
-5,814
-5,409
-5,028
-5,848
-
Net cash used provided by (used for) financing activities
18,721
13,669
15,817
35,297
468,906
-
Net change in cash
15,987
131,931
-368,720
-92,571
212,151
-
Cash at beginning of period
339,794
227,353
596,073
688,644
476,493
-
Cash at end of period
355,886
359,284
227,353
596,073
688,644
-
Free cash flow
Operating cash flow
-26,797
-15,197
-33,606
-21,373
-217,898
-
Capital expenditure
-47,152
-49,524
-131,661
-101,278
-38,394
-
Free cash flow
-73,949
-64,721
-165,267
-122,651
-256,292
-
© 2024 Yahoo. All rights reserved.